- Home
- VERU vs CIA Comparison
VERU vs CIA Comparison
Compare VERU & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- CIA
- Stock Information
- Founded
- VERU 1971
- CIA 1969
- Country
- VERU United States
- CIA United States
- Employees
- VERU N/A
- CIA N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- CIA Life Insurance
- Sector
- VERU Health Care
- CIA Finance
- Exchange
- VERU Nasdaq
- CIA Nasdaq
- Market Cap
- VERU 113.1M
- CIA 140.5M
- IPO Year
- VERU 1990
- CIA N/A
- Fundamental
- Price
- VERU $0.86
- CIA $5.27
- Analyst Decision
- VERU Strong Buy
- CIA
- Analyst Count
- VERU 4
- CIA 0
- Target Price
- VERU $4.00
- CIA N/A
- AVG Volume (30 Days)
- VERU 578.7K
- CIA 158.4K
- Earning Date
- VERU 12-06-2024
- CIA 11-04-2024
- Dividend Yield
- VERU N/A
- CIA N/A
- EPS Growth
- VERU N/A
- CIA N/A
- EPS
- VERU N/A
- CIA 0.43
- Revenue
- VERU $14,091,909.00
- CIA $246,035,000.00
- Revenue This Year
- VERU N/A
- CIA N/A
- Revenue Next Year
- VERU N/A
- CIA $4.17
- P/E Ratio
- VERU N/A
- CIA $12.26
- Revenue Growth
- VERU N/A
- CIA 3.43
- 52 Week Low
- VERU $0.36
- CIA $1.78
- 52 Week High
- VERU $1.92
- CIA $5.32
- Technical
- Relative Strength Index (RSI)
- VERU 53.67
- CIA 73.78
- Support Level
- VERU $0.80
- CIA $4.59
- Resistance Level
- VERU $1.00
- CIA $5.20
- Average True Range (ATR)
- VERU 0.06
- CIA 0.38
- MACD
- VERU 0.01
- CIA 0.08
- Stochastic Oscillator
- VERU 49.81
- CIA 87.69
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.